TECTONIC THERAPEUTIC

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025

17 май 2025 10:40:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

08 май 2025 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference

07 май 2025 08:00:01 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025

15 апр 2025 08:00:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

20 мар 2025 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic to Participate in March Investor Conferences

20 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

Tectonic Announces $185 Million Private Placement

03 фев 2025 06:30:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

30 янв 2025 06:30:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

03 дек 2024 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

26 ноя 2024 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

11 ноя 2024 05:00:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

07 ноя 2024 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

22 окт 2024 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

19 сен 2024 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic to Participate in September Investor Conferences

20 авг 2024 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

14 авг 2024 16:01:00 Источник Nasdaq GlobeNewswire

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

30 июл 2024 16:01:00 Источник Nasdaq GlobeNewswire